+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Animal Biotechnology Market by Product Type, Technology, Application, End-User - Global Forecast to 2030

  • PDF Icon

    Report

  • 193 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5264368
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Animal biotechnology is rapidly transforming the animal health landscape, offering advanced tools and technologies that drive innovation across disease prevention, animal welfare, and sustainable protein production. As the industry responds to new challenges and regulatory shifts, strategic investments and collaborative models are shaping the future of livestock and companion animal management.

Market Snapshot: Animal Biotechnology Market

The Animal Biotechnology Market grew from USD 31.04 billion in 2024 to USD 33.81 billion in 2025. Sustaining robust momentum, it is forecast to expand at a CAGR of 8.49%, reaching USD 50.64 billion by 2030. Business leaders are responding to evolving demands for reliable animal health solutions, leveraging innovations in molecular diagnostics, gene editing, and feed additive optimization to strengthen productivity and resilience across value chains.

Scope & Segmentation

  • Product Types: Recombinant proteins (antibodies, enzymes including lipases, phytases, proteases, and growth hormones), and comprehensive vaccine formats (DNA, inactivated, live attenuated, subunit).
  • Technologies: Cell culture platforms encompassing avian, insect, and mammalian lines (BHK, CHO, Vero cells); genetic engineering techniques, such as gene editing, synthesis, and transgenics; and PCR/DNA sequencing (next-generation and Sanger sequencing, end-point and real-time PCR kits).
  • Applications: Diagnostics (ELISA kits, lateral flow assays, PCR-based tests), drug discovery (lead optimization, preclinical testing, target identification), and feed additives (carbohydrases, phytases, proteases).
  • End-Users: Animal farms (dairy, poultry, swine), contract research organizations (in vitro, in vivo testing), pharmaceutical companies (generic and large pharma), and research laboratories.
  • Geographies: Key regions tracked include the Americas (notably United States, Canada, Brazil), Europe, Middle East & Africa (United Kingdom, Germany, South Africa, and others), and Asia-Pacific (including China, India, Japan, Australia, among others).
  • Company Coverage: Analysis of leading entities such as Zoetis Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim, Ceva Santé Animale, Virbac S.A. and others.

Key Takeaways for Senior Decision-Makers

  • Advanced cell culture and gene editing technologies are reshaping disease resistance approaches and enabling the creation of performance-optimized animal lines.
  • Recombinant proteins and enzyme-integrated feed solutions are driving a concentrated shift toward resource-efficient animal production and improved health metrics.
  • Vaccine innovation is progressing from traditional forms to DNA and subunit platforms that offer enhanced safety and specificity for diverse market needs.
  • Digital analytics, automation, and AI are increasingly integrated into R&D pipelines, accelerating time-to-market and ensuring higher data accuracy in product development.
  • Targeted supply chain strategies and investment in regional manufacturing are quickly becoming essential in mitigating trade and tariff risks for critical materials and reagents.
  • Collaborative research models involving industry leaders, academic institutions, and government agencies are fostering agile innovation and supporting regulatory navigation in the competitive landscape.

Tariff Impact: Navigating Policy-Driven Disruption

The implementation of increased U.S. tariffs on biotechnology imports in 2025 is exerting measurable pressure on operating costs and procurement strategies for animal health stakeholders. Key inputs like specialized media, enzymes, and reagents are subject to heightened duties, prompting a strategic reevaluation of supplier portfolios and investment in nearshoring and local production. Companies are prioritizing vertical integration for enzyme supply and forging new partnerships with regional suppliers to secure continuity despite complex trade environments. Agile, diversified sourcing and risk management remain decisive in maintaining innovation pipelines and end-product availability.

Methodology & Data Sources

This report synthesizes findings from in-depth executive interviews, sector-specific R&D panels, and regulatory expert input. Secondary data is drawn from trusted industry sources, peer-reviewed journals, market intelligence databases, and regulatory filings. Segmentation mapping and regional trend analysis are validated by expert reviews and public reports, ensuring robust and actionable insights for stakeholders.

Why This Report Matters for B2B Leadership

  • Guides strategic resource allocation by highlighting high-growth market segments and emerging regional opportunities.
  • Empowers risk mitigation through insights on tariff policy effects and supply chain adaptation strategies.
  • Supports data-driven planning for investment in advanced technologies and operational excellence.

Conclusion

Staying ahead in animal biotechnology requires agility, strategic partnerships, and an ongoing commitment to technology adoption and regulatory alignment. This report offers clarity on emerging opportunities and actionable intelligence for forward-thinking leadership across the sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Animal Biotechnology Market, by Product Type
8.1. Introduction
8.2. Recombinant Proteins
8.2.1. Antibodies
8.2.2. Enzymes
8.2.2.1. Lipases
8.2.2.2. Phytases
8.2.2.3. Proteases
8.2.3. Growth Hormones
8.3. Vaccines
8.3.1. DNA Vaccines
8.3.2. Inactivated Vaccines
8.3.3. Live Attenuated Vaccines
8.3.4. Subunit Vaccines
9. Animal Biotechnology Market, by Technology
9.1. Introduction
9.2. Cell Culture
9.2.1. Avian Cell Culture
9.2.2. Insect Cell Culture
9.2.3. Mammalian Cell Culture
9.2.3.1. BHK Cells
9.2.3.2. CHO Cells
9.2.3.3. Vero Cells
9.3. Genetic Engineering
9.3.1. Gene Editing
9.3.2. Gene Synthesis
9.3.3. Transgenic Technology
9.4. PCR And DNA Sequencing
9.4.1. Next-Generation Sequencing
9.4.2. PCR Kits
9.4.2.1. End-Point PCR Kits
9.4.2.2. Real-Time PCR Kits
9.4.3. Sanger Sequencing
10. Animal Biotechnology Market, by Application
10.1. Introduction
10.2. Diagnostics
10.2.1. ELISA Kits
10.2.2. Lateral Flow Assays
10.2.3. PCR-Based Tests
10.3. Drug Discovery
10.3.1. Lead Optimization
10.3.2. Preclinical Testing
10.3.3. Target Identification
10.4. Feed Additives
10.4.1. Carbohydrases
10.4.2. Phytases
10.4.3. Proteases
11. Animal Biotechnology Market, by End-User
11.1. Introduction
11.2. Animal Farms
11.2.1. Dairy Farms
11.2.2. Poultry Farms
11.2.3. Swine Farms
11.3. Contract Research Organizations
11.3.1. In Vitro Testing
11.3.2. In Vivo Testing
11.4. Pharmaceutical Companies
11.4.1. Generic Pharma
11.4.2. Large Pharma
11.5. Research Laboratories
12. Americas Animal Biotechnology Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Animal Biotechnology Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Animal Biotechnology Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Zoetis Inc.
15.3.2. Merck & Co., Inc.
15.3.3. Elanco Animal Health Incorporated
15.3.4. Boehringer Ingelheim International GmbH
15.3.5. Ceva Santé Animale S.A.
15.3.6. Dechra Pharmaceuticals PLC
15.3.7. Vetoquinol S.A.
15.3.8. Phibro Animal Health Corporation
15.3.9. Virbac S.A.
15.3.10. IDEXX Laboratories, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ANIMAL BIOTECHNOLOGY MARKET MULTI-CURRENCY
FIGURE 2. ANIMAL BIOTECHNOLOGY MARKET MULTI-LANGUAGE
FIGURE 3. ANIMAL BIOTECHNOLOGY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANIMAL BIOTECHNOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANIMAL BIOTECHNOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANIMAL BIOTECHNOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIPASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHYTASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GROWTH HORMONES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DNA VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY AVIAN CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY INSECT CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY BHK CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CHO CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VERO CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TRANSGENIC TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-POINT PCR KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY REAL-TIME PCR KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY SANGER SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ELISA KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LATERAL FLOW ASSAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR-BASED TESTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LEAD OPTIMIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRECLINICAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CARBOHYDRASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHYTASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PROTEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DAIRY FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY POULTRY FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY SWINE FARMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY IN VITRO TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY IN VIVO TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENERIC PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 105. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 107. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 108. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 109. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 111. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 112. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 114. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 115. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 116. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 117. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 118. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 120. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 121. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 122. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 123. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 124. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 126. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 127. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 128. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 129. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 130. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 131. CANADA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 132. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 133. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 134. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 135. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 136. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 138. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 139. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 140. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 141. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 142. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 143. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 144. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 145. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 146. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 147. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 148. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 159. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 160. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 162. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 163. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 164. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 165. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 166. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 167. BRAZIL ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 177. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 178. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 180. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 181. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 182. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 183. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 184. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 185. ARGENTINA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 202. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 214. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 217. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 218. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 219. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 220. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 221. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 222. UNITED KINGDOM ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 223. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 224. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 225. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 226. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 227. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 228. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 229. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 230. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 231. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 232. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 233. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 234. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 235. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 236. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 237. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 238. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 239. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 240. GERMANY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 241. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 242. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 243. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 244. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 245. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 246. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 247. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 248. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 249. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 250. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 251. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 252. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 253. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 254. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 255. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 256. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 257. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 258. FRANCE ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 268. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 269. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 270. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 271. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 272. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 273. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 274. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 275. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 276. RUSSIA ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 277. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 278. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 279. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 280. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 281. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 282. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 283. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 284. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 285. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 286. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 287. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 288. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 289. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 290. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 291. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 292. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 293. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 294. ITALY ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 295. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 296. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 297. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 298. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 299. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 300. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 301. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 302. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 303. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 304. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 305. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 306. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 307. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 308. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 309. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 310. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 311. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2030 (USD MILLION)
TABLE 312. SPAIN ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ENZYMES, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY VACCINES, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY MAMMALIAN CELL CULTURE, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY GENETIC ENGINEERING, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR AND DNA SEQUENCING, 2018-2030 (USD MILLION)
TABLE 322. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY PCR KITS, 2018-2030 (USD MILLION)
TABLE 323. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 324. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 325. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
TABLE 326. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY FEED ADDITIVES, 2018-2030 (USD MILLION)
TABLE 327. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 328. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MARKET SIZE, BY ANIMAL FARMS, 2018-2030 (USD MILLION)
TABLE 329. UNITED ARAB EMIRATES ANIMAL BIOTECHNOLOGY MA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Animal Biotechnology market report include:
  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Dechra Pharmaceuticals PLC
  • Vetoquinol S.A.
  • Phibro Animal Health Corporation
  • Virbac S.A.
  • IDEXX Laboratories, Inc.

Table Information